Institut National De La Sante Et De La Recherche Medicale

Assistance Publique-hopitaux De Paris

Universite Paris Cité

Ab Science

Imagine Institut Des Maladies Genetiques Necker Enfants Malades

Slimane Allali

Alain Moussy

Jean-Pierre Kinet

Olivier Hermine

Thiago Trovati Maciel

Caroline Carvalho

Rachel Rignault-bricard

A 2-aminoarylthiazole derivative or a pharmaceutically acceptable salt or solvate thereof, in particular masitinib or a pharmaceutically acceptable salt or solvate thereof, for use in the treatment of sickle cell disease in a patient in need thereof. Also, a 2-aminoarylthiazole derivative or a pharmaceutically acceptable salt or solvate thereof, in particular masitinib or a pharmaceutically acceptable salt or solvate thereof, for use in the prevention and/or treatment of acute chest syndrome (ACS) in a sickle cell disease patient in need thereof.

Masitinib for the treatment of sickle cell disease

Growing community of inventors

Meudon, France

Slimane Allali